<DOC>
	<DOCNO>NCT02966769</DOCNO>
	<brief_summary>The objective multicenter retrospective study compare overall survival patient stage IIIA-N2 NSCLC treat neoadjuvant treatment surgery versus definitive chemoradiation . Secondary objective analyze disease-free survival , median survival , locoregional distant relapse well mortality toxicity relate treatment .</brief_summary>
	<brief_title>N2 Lung Cancer Project : Neoadjuvant Treatment Followed Surgery Versus Chemoradiation</brief_title>
	<detailed_description>Based data publish Intergroup 0139 trial , induction therapy follow surgery patient stage IIIA-N2 NSCLC increase overall survival compare exclusive radical chemoradiation treatment . The major handicap study address role surgery IIIA-N2 NSCLC difficulty recruit patient . Therefore , multicenter study necessary confirm hypothesis generate INT 0139 .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Stage IIIA ( N2 ) disease Potentially resectable disease Stage Lung Cancer CT scan PETCT . N2 involvement : necessary pathological proof . No progression induction treatment . T4 N3 stage . Bulky disease resectable .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>